Prostate Cancer - Results from #27460

Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone - Abstract July 15, 2011

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer - Abstract July 15, 2011

Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer - Abstract July 15, 2011

Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer - Abstract July 15, 2011

Diabetes and prostate cancer risk in the REDUCE trial - Abstract July 15, 2011

Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer - Abstract July 14, 2011

Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: A cohort study - Abstract July 14, 2011

New findings in localized and advanced prostate cancer: AUA 2011 review - Abstract July 14, 2011

Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy - Abstract July 14, 2011

The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse - Abstract July 14, 2011

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program - Abstract July 14, 2011

Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information - Abstract July 14, 2011

Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: A nationwide cohort study of 3 009 258 men - Abstract July 14, 2011

Prostate biopsy tracking with deformation estimation - Abstract July 14, 2011

Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: Lessons from the REDUCE study - Abstract July 13, 2011

Racial differences in sexuality profiles among American, Japanese, and Japanese American men with localized prostate cancer - Abstract July 13, 2011

The effects of long-term androgen deprivation therapy on penile length in patients with prostate cancer: A single-center, prospective, open-label, observational study - Abstract July 13, 2011

Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer - Abstract July 13, 2011

Relationship between prostate-specific antigen bounce body fat distribution and body mass index in permanent seed brachytherapy for prostate cancer - Abstract July 13, 2011

Prostate cancer immunotherapy - Abstract July 13, 2011

Page 1374 of 1435